|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> EGFR-IN-9>> Market Analysis Reports |
Market Analysis Reports of EGFR-IN-9 |
|
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) – Pipeline Insight, 2020 ... or cell maintenance by inhibition of apoptosis. EGFR inhibitors Epidermal growth factor ... irreversible, wild type-selective EGFR TKI against EGFR or HER2 Exon20ins and ... mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated ... Cells Expressing Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players ... Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) targeted therapeutics development ... Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) targeted therapeutics under ... Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) targeted therapeutics based ... Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players ... Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) targeted therapeutics development ... Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) targeted therapeutics under ... Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) targeted therapeutics based ... Genmab A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... leukemia (CLL). HuMax-EGFr HuMax-EGFr, the companys cancer ... and neck cancer. HuMax-EGFr is a human antibody that targets ... epidermal growth factor receptor (EGFr), a molecule found on the surface ... fully human antibody HuMax-EGFr (zalutumumab). AMG 714 AMG ... Response Genetics, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , KRAS mutational analysis, EGFR amplification and EGFR mutational analysis and ResponseDX ... KRAS mutational analysis, TS expression, EGFR amplification, and BRAF mutational analysis ... sample is used to determine EGFR amplification and BRAF, EGFR and KRAS ... Bristol-Myers Squibb Company Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... the Epidermal Growth Factor Receptor (EGFR), which is expressed on the surface of certain ... with irinotecan for patients with EGFR-expressing metastatic colorectal cancer (mCRC ... Chugai Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of human epidermal growth factor receptor (EGFR) by blocking the enzyme tyrosine kinase ... . EGFR plays a key role in the growth, ... Amgen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... to the epidermal growth factor receptor (EGFr) and Nplate (romiplostim), a thrombopoietin (TPO ... Array BioPharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... in patients with MM. ARRY-543 - HER2 / EGFR Program Wholly-owned by Array ARRY ... Celldex Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... expressed epidermal growth factor receptor (EGFR), a protein which has been well ... Curis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... is designed as a multi-target inhibitor of HDAC, EGFR, and Her2 and is the subject ... Infinity Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... , such as epidermal growth factor receptor (EGFR)and Human Epidermal Growth Factor ... Micromet, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... to CD33, epidermal growth factor receptor (EGFR), and non-disclosed solid tumor ... Myriad Genetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... target of various cancer drugs, such as EGFR inhibitors and mTOR inhibitors, and ... Quest Diagnostics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... bone marrow biopsies. It offers the EGFR Pathway test for metastatic colorectal ... YM BioSciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... known as epidermal growth factor receptor (EGFR), is designed to treat epithelial cancers and ... Affimed NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... targeting a validated solid tumor target, EGFR-wild type. It is developing Trispecific Abs ... Checkpoint Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and ... Global EGFR Mutation Test Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 ... genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is ... of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are ... and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients ... Global Targeted Drug EGFR RTK Inhibitors for NSCLC Market Growth (Status and Outlook) 2025-2031 ... of the world Targeted Drug EGFR RTK Inhibitors for NSCLC ... with a focus on Targeted Drug EGFR RTK Inhibitors for NSCLC ... an accelerating global Targeted Drug EGFR RTK Inhibitors for NSCLC ... growth opportunities of Targeted Drug EGFR RTK Inhibitors for NSCLC ... |